{"id":"https://openalex.org/W2149805045","doi":"https://doi.org/10.1089/hum.1990.1.4-463","title":"TNF/TIL Human Gene Therapy Clinical Protocol: Addendum to Protocol, May 24, 1990","display_name":"TNF/TIL Human Gene Therapy Clinical Protocol: Addendum to Protocol, May 24, 1990","publication_year":1990,"publication_date":"1990-12-01","ids":{"openalex":"https://openalex.org/W2149805045","doi":"https://doi.org/10.1089/hum.1990.1.4-463","mag":"2149805045"},"language":"en","primary_location":{"id":"doi:10.1089/hum.1990.1.4-463","doi":"https://doi.org/10.1089/hum.1990.1.4-463","is_oa":false,"landing_page_url":"https://doi.org/10.1089/hum.1990.1.4-463","pdf_url":null,"source":{"id":"https://openalex.org/S39730559","display_name":"Human Gene Therapy","issn_l":"1043-0342","issn":["1043-0342","1557-7422"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Gene Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072133376","display_name":"Steven A. Rosenberg","orcid":"https://orcid.org/0000-0002-8939-8910","observed_orcids":["https://orcid.org/0000-0002-8939-8910"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Steven A. Rosenberg","raw_affiliation_strings":["Surgery Branch, NCI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surgery Branch, NCI","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5072133376"],"corresponding_institution_ids":["https://openalex.org/I4210140884"],"apc_list":null,"apc_paid":null,"fwci":0.4969,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.69812844,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"1","issue":"4","first_page":"463","last_page":"471"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.1136000007390976,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9599999785423279},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.6359999775886536},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.921999990940094},{"id":"https://openalex.org/keywords/retroviral-vectors","display_name":"retroviral vectors","score":0.9079999923706055},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.8109999895095825},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.8339999914169312},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.7020000219345093},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7269999980926514},{"id":"https://openalex.org/keywords/g418-selection","display_name":"G418 selection","score":0.7260000109672546},{"id":"https://openalex.org/keywords/neomycin-resistance","display_name":"neomycin resistance","score":0.7910000085830688},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.4230000078678131}],"concepts":[{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.6488243341445923},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.5829441547393799},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5627263784408569},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5466225743293762},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.49295663833618164},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4360896050930023},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41931912302970886},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37817758321762085},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3597054183483124},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24349680542945862},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20165255665779114},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1089/hum.1990.1.4-463","doi":"https://doi.org/10.1089/hum.1990.1.4-463","is_oa":false,"landing_page_url":"https://doi.org/10.1089/hum.1990.1.4-463","pdf_url":null,"source":{"id":"https://openalex.org/S39730559","display_name":"Human Gene Therapy","issn_l":"1043-0342","issn":["1043-0342","1557-7422"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Gene Therapy","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.75}],"study_designs":[{"id":"https://openalex.org/study-designs/study-protocol","display_name":"Study Protocol"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W1896821329","https://openalex.org/W1942232650","https://openalex.org/W2038434279","https://openalex.org/W2255455702"],"related_works":["https://openalex.org/W4253691182","https://openalex.org/W1929577730","https://openalex.org/W2015665258","https://openalex.org/W2130048828","https://openalex.org/W2319534054","https://openalex.org/W2091201553","https://openalex.org/W2054851015","https://openalex.org/W4250616899","https://openalex.org/W2063137842","https://openalex.org/W2741045495"],"abstract_inverted_index":{"I.":[0],"Brief":[1],"Scientific":[2],"Abstract":[3],"A":[4],"tumor":[5,61,112,217,226],"nodule":[6],"will":[7,25,50,70,86,121,155,181,206,229,250,268,282,295,306,334],"be":[8,26,51,72,88,123,156,182,207,230,251,269,279,283,296,335],"resected":[9],"from":[10,192],"a":[11,54,301,341],"patient":[12,128],"with":[13,53,137],"advanced":[14],"cancer":[15,23,127,263],"and":[16,28,64,94,106,163,170,200,216,237,246,300,324],"the":[17,109,126,153,193,198,203,240,243,247,258,312,330],"lymphocytes":[18],"(TIL)":[19],"infiltrating":[20],"into":[21],"this":[22,266],"deposit":[24],"cultured":[27],"expanded":[29,73],"in":[30,36,74,90,129,222,285,298,340],"vitro":[31],"using":[32],"techniques":[33],"previously":[34],"used":[35],"our":[37],"adoptive":[38],"immunotherapy":[39],"protocols.":[40],"When":[41,319],"these":[42],"TIL":[43,85,120,135,162,194,205,276,294,327],"have":[44],"reached":[45],"log":[46],"phase":[47],"growth,":[48],"they":[49,99],"incubated":[52],"retroviral":[55],"vector":[56],"LTSN":[57],"(containing":[58],"genes":[59],"for":[60,65,145,186,221,239],"necrosis":[62,113,227],"factor":[63,114,228],"neomycin":[66],"resistance).":[67],"These":[68,84,118],"cells":[69,81],"then":[71,87,122,171],"culture":[75],"until":[76],"approximately":[77],"4":[78],"\u00d7":[79,160,174],"1010":[80,91,134,161],"are":[82,100,116,328],"achieved.":[83],"cryopreserved":[89],"cell":[92],"aliquots":[93],"tested":[95],"to":[96,107,125,147,158,168,172,184,265,337],"insure":[97],"that":[98,115,277],"free":[101],"of":[102,111,140,179,197,202,212,225,242,257,262,274,311,316,322,332,344],"replication":[103],"competent":[104],"virus":[105],"determine":[108],"levels":[110,236,321],"secreted.":[117],"gene-transduced":[119,275,326],"administered":[124],"escalating":[130,303],"doses":[131],"beginning":[132],"at":[133,164,286,309],"along":[136],"180,000":[138],"IU/kg":[139,339],"IL-2":[141,333],"every":[142],"8":[143],"hr":[144],"up":[146],"5":[148,288],"days.":[149],"Three":[150],"weeks":[151],"later":[152],"dose":[154,273,304,331],"escalated":[157,167],"3":[159,173],"3-weekly":[165],"intervals,":[166],"1011":[169,175],"TIL.":[176],"Extensive":[177],"monitoring":[178],"patients":[180],"performed":[183,208,252],"test":[185],"any":[187],"toxic":[188],"side":[189],"effects":[190],"resulting":[191],"administration.":[195],"Studies":[196],"survival":[199],"distribution":[201],"gene-modified":[204],"by":[209,232,253],"sequential":[210],"sampling":[211],"blood,":[213],"lymph":[214],"nodes,":[215],"biopsy":[218],"material.":[219],"Tests":[220],"vivo":[223],"production":[224],"conducted":[231],"measuring":[233],"serum":[234],"TNF":[235,244],"tests":[238],"presence":[241],"gene":[245,249],"NeoR":[248],"PCR-DNA":[254],"analysis.":[255],"Evaluation":[256],"possible":[259],"therapeutic":[260],"response":[261],"deposits":[264],"therapy":[267],"measured.":[270],"The":[271],"maximum":[272],"can":[278],"safely":[280],"administered,":[281],"determined":[284],"least":[287],"patients.":[289,345],"In":[290],"subsequent":[291,342],"patients,":[292],"transduced":[293],"selected":[297,325],"G418":[299],"similar":[302],"protocol":[305],"begin":[307],"starting":[308],"10%":[310],"established":[313],"safe":[314,320],"number":[315],"unselected":[317],"cells.":[318],"nonselected":[323],"determined,":[329],"raised":[336],"720,000":[338],"series":[343]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}